Table 2.
Correlations between gene mutations and clinical phenotype.
Syndrome | Gene | PCCs (%) | Sympathetic PGL | Parasympathetic PGL | Bilateral/multifocal neoplasia | Malignancy (%) |
---|---|---|---|---|---|---|
MEN 2A | RET | ~50 | Very rare | Extremely rare | + | <3 |
MEN 2B | RET | ~50 | Very rare | Extremely rare | + | <3 |
VHL | VHL | 10–20 | + | Rare | + | 5 |
NF1 | NF1 | 5 | − | − | − | 11 |
PGL1 | SDHD | + | + | + | + | ~5 |
PGL2 | SDHAF2 | − | − | + | + | Not known |
PGL3 | SDHC | − | Rare | + | − | Not known |
PGL4 | SDHB | Rare | + | Rare | + | ~40 |
PGL5 | SDHA | − | + | − | Not known | Not known |
TMEM127 mutation carriers | TMEM127 | 100 | − | − | + | ~5 |
MAX mutation carriers | MAX | 100 | + | Extremely rare | + | ~10 |
PCCs: pheochromocytomas; PGL: paragangliomas; +: present; −: absent.